Call Options

15 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 15, 2023

BUY
$38.16 - $48.86 $198,431 - $254,072
5,200 New
5,200 $254,000
Q3 2022

Nov 14, 2022

BUY
$41.85 - $53.85 $200,880 - $258,480
4,800 New
4,800 $242,000
Q4 2020

Feb 12, 2021

SELL
$47.96 - $67.64 $671,440 - $946,960
-14,000 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$45.41 - $57.07 $99,901 - $125,554
-2,200 Reduced 13.58%
14,000 $662,000
Q2 2020

Aug 13, 2020

BUY
$42.56 - $54.98 $348,992 - $450,836
8,200 Added 102.5%
16,200 $820,000
Q1 2020

May 11, 2020

SELL
$32.37 - $59.36 $760,694 - $1.39 Million
-23,500 Reduced 74.6%
8,000 $340,000
Q4 2019

Feb 12, 2020

SELL
$32.22 - $50.07 $982,710 - $1.53 Million
-30,500 Reduced 49.19%
31,500 $1.5 Million
Q3 2019

Nov 14, 2019

BUY
$33.82 - $48.17 $1 Million - $1.43 Million
29,600 Added 91.36%
62,000 $2.15 Million
Q2 2019

Aug 20, 2019

BUY
$35.42 - $45.0 $566,720 - $720,000
16,000 Added 97.56%
32,400 $1.46 Million
Q1 2019

May 15, 2019

SELL
$28.09 - $39.49 $179,776 - $252,736
-6,400 Reduced 28.07%
16,400 $617,000
Q4 2018

Feb 14, 2019

SELL
$29.83 - $46.51 $885,951 - $1.38 Million
-29,700 Reduced 56.57%
22,800 $730,000
Q3 2018

Nov 14, 2018

BUY
$33.9 - $47.77 $637,320 - $898,076
18,800 Added 55.79%
52,500 $2.47 Million
Q1 2018

May 15, 2018

SELL
$17.46 - $32.59 $160,632 - $299,828
-9,200 Reduced 21.45%
33,700 $912,000
Q4 2017

Feb 14, 2018

SELL
$15.14 - $20.89 $437,546 - $603,721
-28,900 Reduced 40.25%
42,900 $716,000
Q3 2017

Nov 15, 2017

BUY
$16.81 - $21.61 $1.21 Million - $1.55 Million
71,800
71,800 $1.44 Million

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.31B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.